Who Qualifies for Semaglutide GLP-1 Injections for Weight Loss?
Semaglutide GLP-1 injections are an effective weight loss treatment for individuals struggling with obesity or overweight-related health conditions. Our medical team at Inspire Medical Group will evaluate your overall health and weight loss goals to ensure that Semaglutide GLP-1 injections are suitable for you. For more information contact us today or schedule an appointment online. We are conveniently located at 333 West El Camino, Suite 230, Sunnyvale, CA 94087.


Table of Contents:
What are the criteria to qualify for Semaglutide GLP-1 for weight loss?
How much weight can I expect to lose with Semaglutide GLP-1?
How does Semaglutide GLP-1 affect BMI?
Who cannot use Semaglutide GLP-1?
At Inspire Medical Group, we are committed to providing comprehensive and personalized care to our patients, especially in the area of weight management. We recognize the growing interest in Semaglutide GLP-1, marketed under brand names such as Wegovy, for its effectiveness in aiding weight loss. Our team is well-versed in the latest medical guidelines and regulatory approvals to ensure that our patients receive the most appropriate and effective treatments available.
Semaglutide GLP-1 for weight loss is generally recommended for adults who are overweight or obese, as determined by body mass index (BMI). Typically, individuals with a BMI of 30 or higher, or those with a BMI of 27 or higher and weight-related health conditions such as type 2 diabetes or high blood pressure, may be eligible for treatment.
Before starting treatment, healthcare providers evaluate a person’s overall health to ensure suitable Semaglutide GLP-1. Factors such as medical history, potential contraindications, and pregnancy status are also considered. For optimal results, it’s important to pair Semaglutide GLP-1 with lifestyle changes, including a balanced diet and regular exercise, as these contribute to long-term weight management success.
At our practice, the decision to use Semaglutide GLP-1 for weight loss is made collaboratively, taking into account all medical criteria and individual health goals. We are dedicated to supporting our patients every step of the way on their journey to better health and well-being.
When using Semaglutide GLP-1 for weight management, the amount of weight loss varies from person to person. Clinical studies have shown that, when combined with lifestyle changes such as a balanced diet and regular physical activity, many individuals lose an average of 10-15% of their initial body weight over several months. However, the actual amount of weight lost will depend on individual factors such as starting weight, health conditions, and how well the treatment plan is followed.
Semaglutide GLP-1 works by influencing appetite regulation and reducing hunger, making it easier for patients to manage calorie intake. While some people may experience significant weight loss, results can differ based on factors like metabolism and adherence to recommended lifestyle changes. For the best outcomes, it is important to work with healthcare providers who can tailor the treatment to your specific needs and help manage any side effects along the way.
At our practice, we believe Semaglutide GLP-1 is most effective when combined with sustainable lifestyle changes. Our skilled team will support you throughout your weight loss journey, ensuring your treatment is safe and aligned with your health goals.
At Inspire Medical Group, we are committed to providing comprehensive care for patients dealing with type 2 diabetes and obesity. One of the promising treatments we offer is Semaglutide GLP-1, a medication that has shown remarkable effectiveness in managing not only blood sugar levels but also body mass index (BMI) in our patients.
Semaglutide GLP-1, a glucagon-like peptide-1 (GLP-1) receptor agonist, plays a crucial role in regulating appetite and food intake by mimicking the natural hormone GLP-1. It enhances insulin secretion, reduces glucagon release, and slows gastric emptying, which collectively helps decrease appetite and caloric intake, leading to weight loss.
Clinical studies and observations have demonstrated that Semaglutide GLP-1 can lead to significant weight reduction and improvements in BMI. This is due to its ability to influence hormonal and neural pathways that regulate appetite. By creating a negative energy balance, individuals using Semaglutide GLP-1 often experience a gradual decrease in body fat and a noticeable improvement in BMI.
Moreover, Semaglutide GLP-1 has been shown to reduce cravings for high-calorie, high-fat foods, which helps individuals adopt healthier eating behaviors. These changes contribute to more sustainable weight management and improved health outcomes over time.
It’s important to note that while Semaglutide GLP-1 can help significantly reduce BMI, it is most effective when combined with lifestyle modifications such as a balanced diet and regular physical activity. A comprehensive approach that includes both medication and healthy habits leads to the best long-term results for those aiming to manage their weight and improve overall health.
By integrating Semaglutide GLP-1 into our treatment protocols, Inspire Medical Group aims to provide our patients with effective tools to manage their diabetes and obesity, ultimately helping them achieve better health and a higher quality of life.
At Inspire Medical Group, we prioritize patient safety and personalized care when considering Semaglutide GLP-1 for weight loss. While it has shown effectiveness in helping individuals with weight management, it may not be suitable for everyone. Before recommending Semaglutide GLP-1, our healthcare providers conduct a thorough evaluation of each patient’s health status.
Semaglutide GLP-1 is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as studies have shown potential risks. Patients with known allergies to Semaglutide GLP-1 or its components will be offered alternative treatments to avoid allergic reactions. Additionally, individuals with a history of pancreatitis or severe gastrointestinal conditions, such as gastroparesis, should avoid Semaglutide GLP-1, as it could worsen these conditions. Pregnant or breastfeeding women are advised against using Semaglutide GLP-1, and other options are explored to ensure both mother and child’s health are prioritized.
At Inspire Medical Group, patient education and consultation are crucial. We encourage patients to discuss their health conditions with our providers to ensure that treatments, including Semaglutide GLP-1, are tailored to their specific needs and safety. Contact us today to schedule a consultation and learn how we can help you achieve your weight goals. We are conveniently located at 333 West El Camino, Suite 230, Sunnyvale, CA 94087. We serve patients in the Bay Area from Sunnyvale, CA, San Jose, CA, Los Altos CA, Santa Clara CA to Cupertino CA, and beyond.

Additional Services You May Need
▸Primary Care
▸Annual Wellness
▸Sports Physicals
▸Acute Illness Care
▸Immunizations
▸Flu Vaccines
▸TB screenings
▸Women’s Wellness Exam
▸Anxiety
▸Eating Disorders
▸Substance Use Disorders

Additional Services You May Need
▸Primary Care
▸Annual Wellness
▸Sports Physicals
▸Acute Illness Care
▸Immunizations
▸Flu Vaccines
▸TB screenings
▸Women’s Wellness Exam
▸Anxiety
▸Eating Disorders
▸Substance Use Disorders
▸Behavioral Health
▸Marriage Counseling
▸Internal Medicine
▸Chronic Disease Management
▸Diabetes and Hypertension Management
▸Care Coordination
▸COVID-19 Testing
▸COVID-19 vaccinations
▸Telemedicine
▸Allergy Care
▸Cold
▸Cough
▸Prescription Refills
▸Weight-loss
▸Semaglutide GLP-1
▸Tirzepatide
▸Phentermine
▸Vitamin B12 injections
▸Nutrition Counseling and Management